The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth
Open accessAbstract
BACKGROUND: GH therapy requires daily injections over many years and compliance can be difficult to sustain. As growth hormone (GH) is expensive, non-compliance is likely to lead to suboptimal growth, at considerable cost. Thus, we aimed to assess the compliance rate of children and adolescents with GH treatment in New Zealand. METHODS: This was a national survey of GH compliance, in which all children receiving government-funded GH for a four-month interval were included. Compliance was defined as ≥ 85% adherence (no more than one missed dose a week on average) to prescribed treatment. Compliance was determined based on two parameters: either the number of GH vials requested (GHreq) by the family or the number of empty GH vials returned (GHret). Data are presented as mean ± SEM. FINDINGS: 177 patients were receiving GH in the study period, aged 12.1 ± 0.6 years. The rate of returned vials, but not number of vials requested, was positively associated with HVSDS (p < 0.05), such that patients with good compliance had significantly greater linear growth over the study period (p<0.05). GHret was therefore used for subsequent analyses. 66% of patients were non-compliant, and this outcome was not affected by sex, age or clinical diagnosis. However, Maori ethnicity was associated with a lower rate of compliance. INTERPRETATION: An objective assessment of compliance such as returned vials is much more reliable than compliance based on parental or patient based information. Non-compliance with GH treatment is common, and associated with reduced linear growth. Non-compliance should be considered in all patients with apparently suboptimal response to GH treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Text messages could hasten tuberculosis drug compliance
Barclay, E. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61938-8 · Cited by 79
Cited by
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Hughes, I. P., Choong, C., Rath, S., Atkinson, H., Cotterill, A., Cutfield, W., Hofman, P., & Harris, M. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.04.006 · Cited by 32
“While we believe this study is the first to document and analyse in detail the problems of early cessation and prolonged poor response, management strategies for poor response and poor compliance have been developed and are well covered in the literature [8,10,11,16,19, 28,37,38].”
BackgroundInfluentialSelf-citationBackeljauw, P., Blair, J. C., Ferran, J.-M., Kelepouris, N., Miller, B. S., Pietropoli, A., Polak, M., Sävendahl, L., Verlinde, F., & Rohrer, T. R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad159 · Cited by 12
Coutant, R., Nicolino, M., Cammas, B., de Buyst, V., Tauber, M., & Hamel, J.-F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.790169 · Cited by 5
Metadata
- Authors
- Cutfield, W. S., Derraik, J. G. B., Gunn, A. J., Reid, K., Delany, T., Robinson, E., & Hofman, P. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-31
- Volume
- 6
- Issue
- 1
- Pages
- e16223
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2007891815
- Cited by
- 250
- References
- 1
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth. https://app.cochat.ai/papers/10.1371/journal.pone.0016223
- The paper
- Cutfield, W. S., Derraik, J. G. B., Gunn, A. J., Reid, K., Delany, T., Robinson, E., & Hofman, P. L. (2011). Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth. PLoS ONE. https://doi.org/10.1371/journal.pone.0016223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.